bf/NASDAQ:MRNS_icon.jpeg

NASDAQ:MRNS

Marinus Pharmaceuticals

  • Stock

USD

Last Close

0.55

10/02 21:00

Market Cap

67.57M

Beta: 1.16

Volume Today

1.10M

Avg: 544.92K

PE Ratio

−4.02

PFCF: −4.81

OverviewFinancialsAPI

    Description

    Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acut...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1-0.52019-08-082020-12-302022-03-212023-08-102024-11-05

    Revenue (Estimate*)

    5M10M15M20M2019-08-082020-12-302022-03-212023-08-102024-11-05

    *Estimate based on analyst consensus